Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

OBJECTIVE: Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the incomplete understanding of the pathogenic mechanisms and the absence of accurate non-invasive biomarkers. The aim of this study was to identify novel NAFLD therapeutic targets andbiomarkers by conducting liver...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Gut
المؤلفون الرئيسيون: Baselli, Guido Alessandro, Dongiovanni, Paola, Rametta, Raffaela, Meroni, Marica, Pelusi, Serena, Maggioni, Marco, Badiali, Sara, Pingitore, Piero, Maurotti, Samantha, Montalcini, Tiziana, Taliento, Alice Emma, Prati, Daniele, Rossi, Giorgio, Fracanzani, Anna Ludovica, Mancina, Rosellina Margherita, Romeo, Stefano, Valenti, Luca
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Publishing Group 2020
الموضوعات:
Hepatology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497582/
https://ncbi.nlm.nih.gov/pubmed/32001554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319226
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة